SEC Form 4 · accession 0001104659-16-141912
Hepion Pharmaceuticals, Inc. · HEPA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John T Cavan
Officer — Chief Financial Officer
Period of report
Aug 26, 2016
Accepted (ET)
Aug 29, 2016 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583771
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $1.10 | Aug 26, 2016 | A | 18,688 | A | — | Aug 26, 2026 | Common Stock | 18,688 | 118,688 | D |
Explanation of responses
- F1Options vest in three installments as follows: 6,229 options shall vest on each of August 26, 2017 and 2018 and 6,230 shall vest on August 26, 2019.